Sciene | Amgen

SCIENCE

Amgen is a pioneer in the science of using living cells to make biologic medicines. We helped invent the processes and tools that built the global biotech industry—turning it into a leading source of therapies for patients.

Understanding Life. Transforming Medicine.

Some of the greatest advances in science are taking place now inside Amgen. Watch and hear the stories from the scientists making it happen.

Learn More

Science

In this section

Amgen Pipeline

Amgen has created a robust and differentiated pipeline, leveraging state-of-the-art science to create medicines for serious illness.
Introduction in Biotechnology

Amgen was one of the first companies to recognize the potential of modern biotechnology in developing valuable medicines for patients. Today’s biologic medicines have made a significant difference to the lives of patients with serious illnesses.
BiTE® Immuno-Oncology Platform: The Next Generation of Cancer Treatment

BiTE® is a targeted immuno-oncology platform which works by engaging the patient’s own T-cells to accurately identify and then destroy cancer cells. Read more.
Clinical Research

One of the most important steps in the long and careful process of developing new therapies are clinical trials. These involve people volunteering to receive a new therapy and its effects being investigated.
Amgen Biosimilars

Biosimilars offer the potential to increase patient access to vital medicines. Amgen is well positioned to leverage its more than 35 years of experience in biotechnology to create high-quality biosimilars and reliably supply them to patients worldwide.

SCIENCE

Understanding Life. Transforming Medicine.

In this section

Amgen Pipeline

Introduction in Biotechnology

BiTE® Immuno-Oncology Platform: The Next Generation of Cancer Treatment

Clinical Research

Amgen Biosimilars